By Nadia-Elysse Harris | May 17, 2013 03:05 PM EDT
The US Justice Department filed suit Friday, alleging that a NYC fish processor manufactured and distributed fish that could potentially cause serious illness in consumers.
By Susan Scutti | May 16, 2013 02:07 PM EDT
The biopharmaceutical company, which operates in over 100 countries, has issued an update on its oncology pipeline for 2013.
By Evan Winchester | May 15, 2013 06:42 PM EDT
FDA approves new treatment option for ulcerative colitis, a chronic disease that affects about 620,000 Americans.
By Evan Winchester | May 15, 2013 02:24 PM EDT
The drug's active ingredient, radium-223, targets bone metastases in patients with castration-resistant metastatic prostate cancer.
By Evan Winchester | May 14, 2013 07:44 PM EDT
The drug received fast-track approval from the FDA, based on its potential to eliminate medical errors involving improper administration.
By Christie Rizk | May 14, 2013 04:43 PM EDT
The FDA says GMO foods must go through the same testing and approval process as any other product the agency oversees.
By Nadia-Elysse Harris | May 14, 2013 01:59 PM EDT
The US Food and Drug Administration approved new labels that lower the recommended dosage for sleep medications containing zolpidem.
By Anthony Rivas | May 12, 2013 01:16 PM EDT
A study found that chicken treated with the drug roxarsone had increased levels of inorganic arsenic, a carcinogen.
By Anthony Rivas | May 08, 2013 11:24 PM EDT
Wrigley has pulled their caffeinated gum, Alert, off shelves as the FDA begins investigation into the effects of caffeinated foods on kids.
By Jonathan Weiss | May 06, 2013 04:48 PM EDT
In a call to reduce skin cancer rates, the FDA wants manufacturers to put warnings on tanning beds for children under 18.
By Anthony Rivas | May 01, 2013 08:20 PM EDT
The Justice Department is appealing an order for the FDA to make the morning-after pill available to girls and women of all ages.
By Anthony Rivas | Apr 30, 2013 07:29 PM EDT
The FDA approved the morning-after pill, Plan B One-Step, for sale to women 15 years of age and older today.
By Ansa Varughese | Apr 24, 2013 04:51 PM EDT
CD-3 is a new handheld device that the FDA announced they will deploy to curtail the uncontrollable administration of counterfeit and substandard anti-malarial medication. The first deployment will be tested in Ghana.
By Amber Moore | Jan 20, 2013 04:02 PM EST
Botox may be used to treat people with an overactive bladder when other treatments for the conditions have failed, the U.S. Food and Drug Administration announced on Friday.
By Amber Moore | Jan 02, 2013 03:16 PM EST
FDA approved Sirturo (bedaquiline) to treat multiple drug resistant tuberculosis in adults when all other treatments fail.